摘要
虽然100多年前,通过光动力学疗法(PDT)破换微生物的能力发现了它,但是它主要作为癌症治疗剂被开发。近几年,由于多种病原体抗生素耐药菌株不可阻挡的上升,PDT正被认为是使微生物细胞不能产生耐抗力的全能途径。本综述的目的是为了调查作为抗菌光敏剂测试的不同类化合物。其中的一些化合物已经被熟知多年,而其他一些是基于近期的结构原理而合理设计而成。基于四吡咯化合物(其中一些被批准为抗癌制剂)能够有效的产生单线态氧,当他们承受阳离子电荷时,会更加高效广谱,如从大环化合物到卟啉类到卟吩到酞菁到细菌卟吩,从长波长吸收移动到近红外,组织的穿透性会变得更好。对四种主要类型的天然产物:姜黄素、核黄素、金丝桃素和补骨脂素进行了测试。酚酞染料如亚甲蓝和甲苯胺蓝已经通过测试,并且一些已经通过临床批准。许多带有咕吨、三芳基甲烷和靛青结构的非酚酞染料也已通过测试。基于BODIPY、方酸和富勒烯笼的环状结构也能够调节抗菌PDT。最后采用二氧化钛的光催化过程也具有医学用途。设计新的抗菌光敏剂可能需要化学家付出很长时间才能够实现。
关键词: 抗菌光敏剂疗法,细菌,菌绿素,氯,富勒烯,真菌,感染,天然产物,吩噻嗪盐,酞菁,卟啉,二氧化钛光催化,咕吨染料
Current Medicinal Chemistry
Title:Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight
Volume: 22 Issue: 18
Author(s): Rui Yin and Michael R. Hamblin
Affiliation:
关键词: 抗菌光敏剂疗法,细菌,菌绿素,氯,富勒烯,真菌,感染,天然产物,吩噻嗪盐,酞菁,卟啉,二氧化钛光催化,咕吨染料
摘要: Although photodynamic therapy (PDT) was discovered over a hundred years ago by its ability to destroy microorganisms, it has been developed mainly as a cancer therapy. In recent years, due to the inexorable rise in multi-antibiotic resistant strains of pathogens, PDT is being considered as a versatile antimicrobial approach to which microbial cells will not be able to develop resistance. The goal of this review is to survey the different classes of chemical compounds that have been tested as antimicrobial photosensitizers. Some of these compounds have been known for many years, while others have been rationally designed based on recently discovered structural principles. Tetrapyrrole-based compounds (some of which are approved as cancer therapies) that efficiently generate singlet oxygen are more efficient and broad-spectrum when they bear cationic charges, As the macrocycle structure moves from porphyrins to chlorins to phthalocyanines to bacteriochlorins the long wavelength absorption moves to the near-infrared where tissue penetration is better. Four main types of natural products have been tested: curcumin, riboflavin, hypericin and psoralens. Phenothiazinium dyes, such as methylene blue and toluidine blue, have been tested, and some are clinically approved. A variety of non-phenothiazinium dyes with xanthene, triarylmethane and indocyanine structures have also been tested. New ring structures based on BODIPY, squaraine and fullerene cages can also mediate antimicrobial PDT. Finally the process of photocatalysis using titanium dioxide can also have medical uses. Designing new antimicrobial photosensitizers is likely to keep chemists engaged for a long time to come.
Export Options
About this article
Cite this article as:
Rui Yin and Michael R. Hamblin , Antimicrobial Photosensitizers: Drug Discovery Under the Spotlight, Current Medicinal Chemistry 2015; 22 (18) . https://dx.doi.org/10.2174/0929867322666150319120134
DOI https://dx.doi.org/10.2174/0929867322666150319120134 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intraepithelial Neoplasia, Dysplasia and Early Cancer of the Digestive Tract: Modifications in Terminology
Current Cancer Therapy Reviews Predicting Chemotherapy Sensitivity Profiles for Breast Cancer Cell Lines with and Without Stem Cell-Like Features
Current Signal Transduction Therapy Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics Immunohistochemical and Serological 90K / Mac-2BP Detection in Hepatocellular Carcinoma Patients: Different Behaviour of Two Monoclonal Antibodies
Medicinal Chemistry The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell
Current Pharmaceutical Biotechnology Spatiotemporal Regulation of DNA Replication in the Human Genome and its Association with Genomic Instability and Disease
Current Medicinal Chemistry Editorial [Hot Topic: Recent Advances Into the Molecular Mechanisms and Therapeutic Targeting of Hepatocellular Carcinoma (Guest Editors: Dr. Mei-Sze Chua and Li Wang)]
Anti-Cancer Agents in Medicinal Chemistry A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
Current Drug Targets Cell Cycle Control by the CDC25 Phosphatases
Anti-Cancer Agents in Medicinal Chemistry Optimal Management of Prostate Cancer Based on its Natural Clinical History
Current Cancer Drug Targets Recent Advances Using Supercritical Fluid Techniques for Pulmonary Administration of Macromolecules via Dry Powder Formulations
Drug Delivery Letters Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry The Role of PEDF in Tumor Growth and Metastasis
Current Molecular Medicine Editorial (Thematic Issue: Contemporary siRNA Therapeutics and the Current State-of-Art)
Current Pharmaceutical Design Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization
Current Topics in Medicinal Chemistry Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers
Current Drug Targets Design and Synthesis of 1,4-dihydropyridine Derivatives as Anti-cancer Agent
Anti-Cancer Agents in Medicinal Chemistry Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
Current Drug Targets Clinical and Translational Research Challenges in Neuroendocrine Tumours
Current Medicinal Chemistry